# Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

> **NCT04505501** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Thai Red Cross AIDS Research Centre** · enrollment: 14 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** N-803

## Key facts

- **NCT ID:** NCT04505501
- **Lead sponsor:** Thai Red Cross AIDS Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04505501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04505501, "Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04505501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*